Literature DB >> 19578779

Alterations of glycosaminoglycan disaccharide content and composition in colorectal cancer: structural and expressional studies.

Dimitrios Kalathas1, Dimitrios A Theocharis, Dimitrios Bounias, Dora Kyriakopoulou, Nikoletta Papageorgakopoulou, Michael S Stavropoulos, Demitrios H Vynios.   

Abstract

The glycosaminoglycans are implicated in many processes important in the growth and progression of malignant tumors. In the present study glycosaminoglycans were purified from healthy, macroscopically normal and cancerous specimens of different anatomic sites and different stages of cancer and analyzed by FACE after chondroitinases and sulfatases digestion. The cancerous samples contained increased levels of 6-sulfated unsaturated disaccharides compared to macroscopically normal and healthy samples, the increase being stage-related. The differences in sulfation were found to be related to the anatomic site and the stage of cancer. RT-PCR analysis of 4-sulfotransferase mRNA revealed its presence in decreasing amounts as the stage of the cancer increased. Furthermore, the percent content of hyaluronan disaccharides was elevated in macroscopically normal samples compared to the cancerous, and in addition, it was much more elevated than that of healthy samples. Haluronan levels increase with stage in cancerous tissues. Therefore, it could be concluded that the glycosaminoglycans in colorectal cancer are biosynthetically directed to contribute in different ways depending on the cancer stage and anatomical site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578779

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

1.  Down-regulation of chondroitin 4-O-sulfotransferase-1 by Wnt signaling triggers diffusion of Wnt-3a.

Authors:  Satomi Nadanaka; Hiroki Kinouchi; Kayo Taniguchi-Morita; Jun-ichi Tamura; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

2.  A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinoma.

Authors:  Nabil Mohie Abdel-Hamid; M M Abouzied; M H Nazmy; M A Fawzy; A S Gerges
Journal:  Tumour Biol       Date:  2015-09-19

3.  Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility.

Authors:  Thomas Mandel Clausen; Marina Ayres Pereira; Nader Al Nakouzi; Htoo Zarni Oo; Mette Ø Agerbæk; Sherry Lee; Maj Sofie Ørum-Madsen; Anders Riis Kristensen; Amal El-Naggar; Paul M Grandgenett; Jean L Grem; Michael A Hollingsworth; Peter J Holst; Thor Theander; Poul H Sorensen; Mads Daugaard; Ali Salanti
Journal:  Mol Cancer Res       Date:  2016-09-21       Impact factor: 5.852

4.  CHST11/13 Regulate the Metastasis and Chemosensitivity of Human Hepatocellular Carcinoma Cells Via Mitogen-Activated Protein Kinase Pathway.

Authors:  Huimin Zhou; Yanping Li; Xiaobo Song; Yongfu Zhao; Lei Cheng; Lifen Zhao; Li Jia
Journal:  Dig Dis Sci       Date:  2016-03-18       Impact factor: 3.199

5.  CHSY1 promoted proliferation and suppressed apoptosis in colorectal cancer through regulation of the NFκB and/or caspase-3/7 signaling pathway.

Authors:  Lifeng Zeng; Jinrong Qian; Xiaojiang Luo; Aiqun Zhou; Zhiyong Zhang; Quangang Fang
Journal:  Oncol Lett       Date:  2018-09-03       Impact factor: 2.967

6.  Changes in composition and sulfation patterns of glycoaminoglycans in renal cell carcinoma.

Authors:  Ebru Ucakturk; Orkun Akman; Xiaojun Sun; Dilek Ertoy Baydar; Anil Dolgun; Fuming Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2015-12-14       Impact factor: 2.916

7.  The chondroitin/dermatan sulfate synthesizing and modifying enzymes in laryngeal cancer: expressional and epigenetic studies.

Authors:  Dimitrios Kalathas; Irene-Eva Triantaphyllidou; Nicholas S Mastronikolis; Panos D Goumas; Thoedore A Papadas; Gabriel Tsiropoulos; Demitrios H Vynios
Journal:  Head Neck Oncol       Date:  2010-10-07

8.  Primary ovarian carcinomas and abdominal metastasis contain 4,6-disulfated chondroitin sulfate rich regions, which provide adhesive properties to tumour cells.

Authors:  Myrtille J E Vallen; Samuel Schmidt; Arie Oosterhof; Johan Bulten; Leon F A G Massuger; Toin H van Kuppevelt
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

9.  Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character.

Authors:  Iván Fernández-Vega; Olivia García-Suárez; Beatriz García; Ainara Crespo; Aurora Astudillo; Luis M Quirós
Journal:  BMC Cancer       Date:  2015-10-20       Impact factor: 4.430

10.  Chondroitin sulfate-E is a negative regulator of a pro-tumorigenic Wnt/beta-catenin-Collagen 1 axis in breast cancer cells.

Authors:  Catherine M Willis; Michael Klüppel
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.